Memorial Sloan Kettering Cancer Center: Central Nervous System Neoplasms trials
The registry lists 21 Central Nervous System Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 9 have results posted.
Phase 1 9Phase 2 14No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Mirdametinib in People With Central Nervous System TumorsRecruitingNCT07539441Phase 1/2
- [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System TumorsCompletedNCT00832598Not applicableResults posted
- Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaCompletedNCT00589784Phase 2Results posted
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant GliomaCompletedNCT00498927Phase 2Results posted
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsCompletedNCT00470366Phase 2Results posted
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
- Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinCompletedNCT00423852Phase 1/2Results posted
- Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate CancerCompletedNCT00085566Phase 1/2Results posted
- Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With MedulloblastomaCompletedNCT00058370Not applicableResults posted
- Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 2Results posted
- A Study of Avutometinib for People With Solid Tumor CancersActive, not recruitingNCT06104488Phase 1
- Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to TreatmentActive, not recruitingNCT02932280Phase 1/2
- Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell TumorsCompletedNCT00070096Phase 2
- Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaCompletedNCT00036972Phase 1
- Taurolidine in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00022360Phase 1
- Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00022256Phase 2
- Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00005637Phase 1
- Temozolomide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004113Phase 2
- High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 2
- Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With OligodendrogliomaCompletedNCT00003101Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1